Something slightly curious took place today in the comments to this article on the Times (£) website: Advisers on e-cigarettes
In case you're unaware, the article in question highlights the lack of declarations of interests by the expert panel the MHRA convened to discuss regulating electronic cigarettes.
In particlar, severeal of these experts have strong links to the pharmaceutical industry, either in consulting positions or as shareholders: All concerning smoking cessation products.
So, the following comment was posted by the username "MHRA" this morning, and signed by Dr. Ian Hudson. By 3.30pm, it no longer appeared on the site. Commenters on the Times website are able to delete comments they've posted, although it could easily have been the Times which removed the comment:
I wonder what's going on here?
In case you're unaware, the article in question highlights the lack of declarations of interests by the expert panel the MHRA convened to discuss regulating electronic cigarettes.
In particlar, severeal of these experts have strong links to the pharmaceutical industry, either in consulting positions or as shareholders: All concerning smoking cessation products.
So, the following comment was posted by the username "MHRA" this morning, and signed by Dr. Ian Hudson. By 3.30pm, it no longer appeared on the site. Commenters on the Times website are able to delete comments they've posted, although it could easily have been the Times which removed the comment:
The article by Alex Ralph (Advisers on e-cigarettes failed to declare their interests in Big Pharmas products) misrepresents the way the MHRA handled conflicts of interests in the case of the Nicotine Containing Products Working Group. The MHRA has a strict conflicts of interests policy in place, outlined in full on our website, this applies to chairpersons and members of the Commission on Human Medicines and any ad hoc or working groups it establishes.
All members of the Nicotine Containing Products Working Group made full statements of any relevant interests in their annual declarations. Mr Ralph states that no interests were declared at the January 2013 meeting, where in fact interests were clearly declared by two members as recorded in the minutes.
No interests were declared at the beginning of the meeting as initial items were general in nature, where the discussion was product-specific relevant interests were declared and taken into consideration when deciding the extent of those members participation in the discussion and recorded in the minutes under that specific item. One of these members was then limited in their participation to the group, the other was permitted to participate as the interest was non-personal (meaning no direct remuneration was received by the member) and non-specific (not related to the item being discussed).
The vast majority of the content considered by the working group at both of the meetings was of a broad nature on topics such as the tobacco Products Directive and not product-specific.
Given the highly technical nature of the MHRAs work, it is difficult to find experts with the relevant expertise who do not have any form of interaction with the pharmaceutical industry, either direct or indirect. Their interests are, however, considered and assessed when deciding on the appropriate level of participation in discussions.
Yours sincerely,
Dr Ian HudsonDirector of Licensing
Medicines and Healthcare products Regulatory Agency
I wonder what's going on here?